Join AI host Ben Synth as he examines BPC-157's remarkable animal research showing accelerated healing, while confronting a stark reality: virtually no rigorous human clinical trials exist. From Zagreb rat studies to biohacking forums, we explore why this peptide's promising mechanisms haven't translated to proven human medicine and what that gap reveals about drug development.

Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

This content was created in partnership and with the help of Artificial Intelligence AI.